Literature DB >> 1638764

Possible role of IL-2 deficiency for hypogammaglobulinaemia in patients with common variable immunodeficiency.

J A Rump1, A Jahreis, M Schlesier, R Dräger, I Melchers, H H Peter.   

Abstract

Common variable immunodeficiency (CVID) patients are unable to produce specific immunoglobulins after antigen contact in vivo. The aim of this study was to investigate whether in some cases of CVID a decreased de novo synthesis of IL-2 might be the cause of immunodeficiency and whether this deficiency can be corrected by IL-2 supplementation in vitro. Mononuclear cells from 17 CVID patients and from 10 healthy controls were cultured with monoclonal anti-CD3 antibody OKT3, pokeweed mitogen (PWM) or tetanus toxoid (TT) to stimulate IL-2 synthesis. In parallel, in vitro IgG and IgM synthesis was stimulated with Staphylococcus aureus Cowan I (SAC), PWM or TT in the presence or absence of IL-2. While lymphocytes of 11 out of 17 patients produced low to normal amounts of IL-2 upon stimulation with anti-CD3, only three patients showed low IL-2 production in response to PWM and five in response to TT. Regarding immunoglobulin synthesis in vitro, five patients completely failed to produce IgM or IgG upon stimulation with PWM, SAC or TT irrespective of the addition of IL-2. By contrast, four patients did not show any defect in vitro and synthesized normal amounts of IgM and IgG with any of the three stimuli. Finally, eight patients could be reconstituted for PWM-, SAC- and TT-induced IgM and/or IgG synthesis in vitro, by adding IL-2 to the culture system. This enhancing effect of IL-2 could be blocked by adding anti-IL-2 receptor antibodies to the cultures. Our findings indicate that a defective IL-2 synthesis after antigen stimulation may be one reason for the impaired immunoglobulin production in some cases of CVID.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1638764      PMCID: PMC1554446          DOI: 10.1111/j.1365-2249.1992.tb06933.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Abnormalities in CD4+ T lymphocyte subsets in patients with common variable immunodeficiency.

Authors:  Y Lebranchu; G Thibault; D Degenne; P Bardos
Journal:  Clin Immunol Immunopathol       Date:  1991-10

2.  Quantitative measurements of T- and B-cell function in "variable" primary hypogammaglobulinaemia: evidence for a consistent B-cell defect.

Authors:  E G de la Concha; G Oldham; A D Webster; G L Asherson; T A Platts-Mills
Journal:  Clin Exp Immunol       Date:  1977-02       Impact factor: 4.330

3.  T cell receptor triggering induces responsiveness to interleukin 1 and interleukin 2 but does not lead to T cell proliferation.

Authors:  S C Meuer; K H Meyer zum Büschenfelde
Journal:  J Immunol       Date:  1986-06-01       Impact factor: 5.422

4.  Induction of IgM production by pokeweed mitogen and interleukin-2: different responses by human peripheral blood cells and tonsil cells.

Authors:  R W Sauerwein; G C Mudde; W C Vooys; W G van der Meer; G C de Gast; L A Aarden
Journal:  Clin Immunol Immunopathol       Date:  1986-06

5.  Elevated serum interleukin-6 associated with a failure in B cell differentiation in common variable immunodeficiency.

Authors:  D C Adelman; T Matsuda; T Hirano; T Kishimoto; A Saxon
Journal:  J Allergy Clin Immunol       Date:  1990-10       Impact factor: 10.793

6.  Accelerated breakdown of immunoglobulin G (IgG) in myotonic dystrophy: a hereditary error of immunoglobulin catabolism.

Authors:  R D Wochner; G Drews; W Strober; T A Waldmann
Journal:  J Clin Invest       Date:  1966-03       Impact factor: 14.808

7.  Analysis of B cell dysfunction in patients with common variable immunodeficiency by using recombinant interleukin 2.

Authors:  T Ariga; M Okano; Y Takahashi; Y Sakiyama; S Matsumoto
Journal:  Tohoku J Exp Med       Date:  1987-05       Impact factor: 1.848

8.  The role of suppressor cells in the pathogenesis of common variable hypogammaglobulinemia and the immunodeficiency associated with myeloma.

Authors:  T A Waldmann; S Broder; R Krakauer; R P MacDermott; M Durm; C Goldman; B Meade
Journal:  Fed Proc       Date:  1976-07

9.  Defective DNA synthesis by T cells in acquired 'common-variable' hypogammaglobulinaemia on stimulation with mitogens.

Authors:  M E North; G P Spickett; J Allsop; A D Webster; J Farrant
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

10.  T cell unresponsiveness to the mitogenic activity of OKT3 antibody results from a deficiency of monocyte Fc gamma receptors for murine IgG2a and inability to cross-link the T3-Ti complex.

Authors:  J L Ceuppens; F J Bloemmen; J P Van Wauwe
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

View more
  11 in total

1.  Identification of a subset of common variable immunodeficiency patients with impaired B-cell protein tyrosine phosphorylation.

Authors:  R Schwartz; Y B Porat; Z Handzel; Z Sthoeger; B Z Garty; R Confino-Cohen; J Levy; I Zan-Bar
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

2.  Deficiency of somatic hypermutation of immunoglobulin G transcripts is a better predictor of severe respiratory tract infections than lack of memory B cells in common variable immunodeficiency.

Authors:  Lone Schejbel; Hanne Marquart; Vagn Andersen; Henrik Permin; Pernille Andersen; Arne Svejgaard; Torben Barington
Journal:  J Clin Immunol       Date:  2005-07       Impact factor: 8.317

3.  Two novel cationic staphylococcal proteins induce IL-2 secretion, proliferation and immunoglobulin synthesis in peripheral blood mononuclear cells (PBMC) of both healthy controls and patients with common variable immunodeficiency (CVID).

Authors:  A Jahreis; Y Yousif; J A Rump; R Dräger; A Vogt; H H Peter; M Schlesier
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

4.  Serum soluble CD23 in patients with hypogammaglobulinaemia.

Authors:  A S Bansal; M R Haeney; S Cochrane; R S Pumphrey; L M Green; M Bhavnani; P B Wilson
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

5.  Common variable immunodeficiency (CVID) and MxA-protein expression in blood leucocytes.

Authors:  J A Rump; D Jakschiess; U Walker; M Schlesier; P von Wussow; H H Peter
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

6.  Intestinal B cell defects in common variable immunodeficiency.

Authors:  E W Herbst; M Armbruster; J A Rump; H P Buscher; H H Peter
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

7.  Impaired up-regulation of CD70 and CD86 in naive (CD27-) B cells from patients with common variable immunodeficiency (CVID).

Authors:  C Groth; R Drager; K Warnatz; G Wolff-Vorbeck; S Schmidt; H Eibel; M Schlesier; H-H Peter
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

8.  A double-blind, placebo-controlled, crossover therapy study with natural human IL-2 (nhuIL-2) in combination with regular intravenous gammaglobulin (IVIG) infusions in 10 patients with common variable immunodeficiency (CVID).

Authors:  J A Rump; A Jahreis; M Schlesier; S Stecher; H H Peter
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

Review 9.  Autoimmunity in common variable immunodeficiency.

Authors:  Susana Lopes-da-Silva; Luiz Vicente Rizzo
Journal:  J Clin Immunol       Date:  2008-04-29       Impact factor: 8.317

Review 10.  The genetics of hypogammaglobulinemia.

Authors:  Bodo Grimbacher; Alejandro A Schäffer; Hans-Hartmut Peter
Journal:  Curr Allergy Asthma Rep       Date:  2004-09       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.